CalmiGo

Molecule key to functional brain rejuvenation identified

Latest articles

Longevity senotherapeutics report: Insilico Medicine

Insilico – on a mission to accelerate senescence drug discovery and development by continuously inventing and deploying new AI technologies. Over the coming weeks, we...

Aging well: the new human imperative

Prof Andrew Scott touts the importance of compressing morbidity and aging well to realise multi-trillion dollar benefit of increasing life expectancy. Earlier this year, we...

Targeting senescence improves kidney regenerative functions

A new study finds that the administration of a compound selectively toxic to senescent cells, can improve functional renal recovery, reduce fibrosis and increase...

US Special Ops will test antiaging pill

From delaying the onset of aging, to improving recovery time, the US military has its sights set on the age of marvel. From duct tape...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...
Seno

Editor's picks

Longevity senotherapeutics report: Insilico Medicine

Insilico – on a mission to accelerate senescence drug discovery and development by continuously inventing and deploying new AI technologies. Over the coming weeks, we...

Aging well: the new human imperative

Prof Andrew Scott touts the importance of compressing morbidity and aging well to realise multi-trillion dollar benefit of increasing life expectancy. Earlier this year, we...

Targeting senescence improves kidney regenerative functions

A new study finds that the administration of a compound selectively toxic to senescent cells, can improve functional renal recovery, reduce fibrosis and increase...
CalmiGo

Click the globe for translations.

Discovery could have important implications for the health of aging brains and development of therapies for neurodegenerative diseases.

Recent studies suggest that new brain cells are being formed every day in response to injury, physical exercise and mental stimulation. Glial cells, and in particular the ones called oligodendrocyte progenitors, are highly responsive to external signals and injuries and can detect changes in the nervous system and form new myelin, which wraps around nerves and provides metabolic support and accurate transmission of electrical signals.

As we age, less myelin is formed in response to external signals, and this progressive decline has been linked to the age-related cognitive and motor deficits detected in older people. Impaired myelin formation also has been reported in older individuals with neurodegenerative diseases such as Multiple Sclerosis or Alzheimer’s and identified as one of the causes of their progressive clinical deterioration.

Longevity.Technology: It’s an exciting time for glial cell research; new work from the University of Illinois at Chicago shows that glial cells can grow for hours after death, and this research from the Advanced Science Research Center at the Graduate Center, CUNY shows that oligodendroglial cells can regenerate and this work demonstrates that TET1 modifies the DNA in specific glial cells in adult brains so they can form new myelin in response to injury.

Now a new study from the Neuroscience Initiative team at the Advanced Science Research Center at The Graduate Center, CUNY (CUNY ASRC) has identified a molecule called ten-eleven-translocation 1 (TET1) as a necessary component of myelin repair. The research, published in Nature Communications, shows that TET1 modifies the DNA in specific glial cells in adult brains so they can form new myelin in response to injury.

“We designed experiments to identify molecules that could affect brain rejuvenation,” said Sarah Moyon, PhD, a research assistant professor with the CUNY ASRC Neuroscience Initiative and the study’s lead author. “We found that TET1 levels progressively decline in older mice, and with that, DNA can no longer be properly modified to guarantee the formation of functional myelin [1].”

Combining whole-genome sequencing bioinformatics, the authors showed that the DNA modifications induced by TET1 in young adult mice were essential to promote a healthy dialogue among cells in the central nervous system and for guaranteeing proper function. The authors also demonstrated that young adult mice with a genetic modification of TET1 in the myelin-forming glial cells were not capable of producing functional myelin, and therefore behaved like older mice [2].

Professor Casaccia
Patrizia Casaccia, founding director of the CUNY ASRC Neuroscience Initiative.

“This newly identified age-related decline in TET1 may account for the inability of older individuals to form new myelin,” said Patrizia Casaccia, founding director of the CUNY ASRC Neuroscience Initiative, a professor of Biology and Biochemistry at The Graduate Center, CUNY, and the study’s primary investigator. “I believe that studying the effect of aging in glial cells in normal conditions and in individuals with neurodegenerative diseases will ultimately help us design better therapeutic strategies to slow the progression of devastating diseases like multiple sclerosis and Alzheimer’s [1].”

The discovery could also have important implications for molecular rejuvenation of aging brains in healthy individuals, said the researchers. Future studies aimed at increasing TET1 levels in older mice are underway to define whether the molecule could rescue new myelin formation and favour proper neuro-glial communication. The research team’s long-term goal is to promote recovery of cognitive and motor functions in older people and in patients with neurodegenerative diseases.

Longevity.Technology reached out to Dr Moyon to find out more about the pathway from research to clinical therapy and the sort of timeframe that might be involved.

“More work is needed,” explained Dr Moyon. “But the first step, ongoing in our laboratory, is to test whether increasing TET1 in glial cells in old mice is sufficient to rejuvenate these glial cells and enhance myelin repair in aging. If confirmed, that would open new exciting venues to potentially lead to novel therapeutic approaches.

“There are many types of glial cells in the adult brain and they can definitely be considered a source for rejuvenation therapy, especially since they have been shown to be involved in many neurological diseases. The big question is how can one reactivate and rejuvenate them efficiently. We believe that increase TET1 expression in this specific glial cells (oligodendroglial cells) could be a way to accelerate remyelination and repair, in diseases such as Multiple Sclerosis for example.”

[1] https://asrc.gc.cuny.edu/headlines/2021/06/researchers-identify-a-molecule-critical-to-functional-brain-rejuvenation/
[2] https://www.nature.com/articles/s41467-021-23735-3

Images courtesy of The Advanced Science Research Center at The Graduate Center, CUNY (CUNY ASRC)

Comment on this article

Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.
CalmiGo

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Spermidine: the mind-enhancing supplement

Scientists are finding that a high intake of dietary spermidine could slow down (or reverse) the brain aging process. Memory loss and slower brain function...
Seno

Related articles

Buck Institute announces aging clock for immunosenescence

10th hallmark of aging? Buck claims actionable clock can predict immunological health and chronic diseases of aging; research highlights the critical role of the...

Brigham and Wyss collaborate on Diagnostic Accelerator

Harvard’s Wyss Institute and Brigham and Women’s Hospital launch Diagnostic Accelerator which aims to create new diagnostic technologies through deep collaborations driven by unmet...

Genetic control of aging – is it time for a rethink?

National Institute of Health scientists discover that bacteria may drive activity of many hallmark aging genes in flies. To better understand the role of bacteria...

Longevity of the lobster and the implications for humanity

American lobster leads discoveries in longevity research – perhaps life really is better under the sea. The American lobster is known for having a longevity...

New treatment halts Alzheimer’s progression in monkeys

Therapy manipulates immune system to slow neurodegeneration without triggering dangerous inflammation in the process. A new therapy prompts immune defence cells to swallow misshapen proteins,...
Seno